Trial
NCT00312286
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Takeda
Collaborators
—
Condition
Papillomavirus Infections
Intervention
851B
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-23